Lakshmira Vindra

Lakshmira Vindra, endocrinologist and NEJM editorial fellow, outlines diabetes physiology and trial evidence with clarity. She walks through insulin types and when to start therapy. The conversation explains the QWINT-1 trial comparing once-weekly insulin to daily glargine. They discuss hypoglycemia differences, practical patient phenotypes, and oral alternatives to minimize injections.